John Markels - Net Worth and Insider Trading
John Markels Net Worth
The estimated net worth of John Markels is at least $87,869 dollars as of 2024-11-13. John Markels is the Director of Sangamo Therapeutics Inc and owns about 32,484 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $87,869. Details can be seen in John Markels's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Markels has not made any transactions after 2022-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Markels
John Markels Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Markels owns 2 companies in total, including Sangamo Therapeutics Inc (SGMO) , and Arcturus Therapeutics Holdings Inc (ARCT) .
Click here to see the complete history of John Markels’s form 4 insider trades.
Insider Ownership Summary of John Markels
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2022-06-03 | director |
| ARCT | Arcturus Therapeutics Holdings Inc | 2022-12-08 | director |
John Markels Latest Holdings Summary
John Markels currently owns a total of 1 stock. John Markels owns 32,484 shares of Sangamo Therapeutics Inc (SGMO) as of June 3, 2022, with a value of $87,869.
Latest Holdings of John Markels
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2022-06-03 | 32,484 | 2.71 | 87,869 |
Holding Weightings of John Markels
John Markels Form 4 Trading Tracker
According to the SEC Form 4 filings, John Markels has made a total of 1 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sangamo Therapeutics Inc is the acquisition of 6,784 shares on June 3, 2022, which cost John Markels around $25,033.
Insider Trading History of John Markels
- 1
John Markels Trading Performance
GuruFocus tracks the stock performance after each of John Markels's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Markels is 48.66%. GuruFocus also compares John Markels's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Markels within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Markels's insider trading performs compared to the benchmark.
Performance of John Markels
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.05 | | | | | |
| Relative Return to S&P 500(%) | 21.94 | | | | | |
John Markels Ownership Network
Ownership Network List of John Markels
Ownership Network Relation of John Markels
John Markels Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
John Markels is the director of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, John Markels made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
John Markels Mailing Address
Above is the net worth, insider trading, and ownership report for John Markels. You might contact John Markels via mailing address: C/o Sangamo Therapeutics, Inc., Point Richmond Tech Ctr, 501 Canal Blvd., Richmond Ca 94804.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
